In quiet debut, Alzheimer's drug finds questions, skepticism
The first new Alzheimers treatment in more than 20 years was hailed as a breakthrough when regulators approved it more than four months ago, but its rollout...
The first new Alzheimers treatment in more than 20 years was hailed as a breakthrough when regulators approved it more than four months ago, but its rollout...